Zhiyi Biotech Raised $45 Million In Series B Funding Round To Accelerate The Clinical Development Of Lbps Pipelines
Jul 07, 2022•about 3 years ago
Amount Raised
$45 Million
Round Type
series b
Description
Recently, Zhiyi Biotech announced that it has raised $15 million in its B++ funding round. The funds will be used to boost the clinical development of the company's live biotherapeutic products (LBPs) pipelines. It's worth mentioning that Zhiyi has successfully completed a total of $45 Million in B, B+ and B++ funding , with investors including Qingkong SinoKing Capital, SDIC Venture Capital, KIP etc.
FundzWatch™ Score
64
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech